0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Trans-p-hydroxycinnamicacid Market Outlook, In‑Depth Analysis & Forecast to 2031
Published Date: November 2025
|
Report Code: QYRE-Auto-34H16552
Home | Market Reports | Science| Chemistry
Global Trans p hydroxycinnamicacid Market Research Report 2024
BUY CHAPTERS

Global Trans-p-hydroxycinnamicacid Market Outlook, In‑Depth Analysis & Forecast to 2031

Code: QYRE-Auto-34H16552
Report
November 2025
Pages:134
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Trans-p-hydroxycinnamicacid Market

The global Trans-p-hydroxycinnamicacid market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Trans-p-hydroxycinnamicacid (CAS:7400-08-0;501-98-4) is a white powder crystal with a molecular formula of C9H8O3. It is one of the three isomers of hydroxycinnamic acid. It is a white solid that is only slightly soluble in water but very soluble in ethanol and diethyl ether.
From a downstream perspective, Medical accounted for % of 2024 revenue, surging to US$ million by 2031 (CAGR: % from 2025–2031).
Trans-p-hydroxycinnamicacid leading manufacturers including Shanxi Yongjin Group, Blue California, Zaoyang Cixiang Medical Technology, Changzhou Mingsheng Biotechnology, Wuhan Landmark Industrial, Shandong Yangcheng Biotechnology, etc., dominate supply; the top five capture approximately % of global revenue, with Shanxi Yongjin Group leading 2024 sales at US$ million.
Regional Outlook:
North America rose from US$ million in 2024 to a forecast US$ million by 2031 (CAGR %).
Asia‑Pacific will expand from US$ million to US$ million (CAGR  %), led by China (US$ million in 2024, % share rising to % by 2031), Japan (CAGR %), South Korea (CAGR %), and Southeast Asia (CAGR %).
Europe is set to grow from US$ million to US$ million (CAGR %), with Germany projected to hit US$ million by 2031 (CAGR %).

Report Includes:

This definitive report equips CEOs, marketing directors, and investors with a 360° view of the global Trans-p-hydroxycinnamicacid market, seamlessly integrating production capacity and sales performance across the value chain. It analyzes historical production, revenue, and sales data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies volume and value, growth rates, technical innovations, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.
Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries. Each region’s dominant products, competitive landscape, and downstream demand trends are clearly detailed.
Critical competitive intelligence profiles manufacturers—capacity, sales volume, revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise supply‑chain overview maps upstream suppliers, manufacturing technologies, cost structures, and distribution dynamics to identify strategic gaps and unmet demand.
Market Segmentation

Scope of Trans-p-hydroxycinnamicacid Market Report

Report Metric Details
Report Name Trans-p-hydroxycinnamicacid Market
Segment by Type
  • Purity≥98%
  • Purity≥99%
  • Others
Segment by Application
  • Medical
  • Agriculture
  • Cosmetics
  • Electronics
  • Others
Production by Region
  • North America
  • Europe
  • China
  • Japan
Sales by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Shanxi Yongjin Group, Blue California, Zaoyang Cixiang Medical Technology, Changzhou Mingsheng Biotechnology, Wuhan Landmark Industrial, Shandong Yangcheng Biotechnology
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the Trans-p-hydroxycinnamicacid study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
  • Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
  • Chapter 3: Maps global production capacity, utilization, and market share (2020–2031), identifies efficient hubs, reveals regulatory/trade policy impacts and bottlenecks.
  • Chapter 4: Dissects the manufacturer landscape—ranks by volume and revenue, analyzes profitability and pricing, maps production bases, details manufacturer performance by product type and evaluates concentration alongside M&A moves.
  • Chapter 5: Unlocks high margin product segments—compares sales, revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
  • Chapter 6: Targets downstream market opportunities—evaluates sales, revenue, and pricing by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
  • Chapter 7: North America—breaks down sales and revenue by Type, by Application and country, profiles key manufacturers and assesses growth drivers and barriers.
  • Chapter 8: Europe—analyses regional sales, revenue and market by Type, by Application and manufacturers, flagging drivers and barriers.
  • Chapter 9: Asia Pacific—quantifies sales and revenue by Type, by Application, and region/country, profiles top manufacturers, and uncovers high potential expansion areas.
  • Chapter 10: Central & South America—measures sales and revenue by Type, by Application, and country, profiles top manufacturers, and identifies investment opportunities and challenges.
  • Chapter 11: Middle East and Africa—evaluates sales and revenue by Type, by Application, and country, profiles key manufacturers, and outlines investment prospects and market hurdles
  • Chapter 12: Profiles manufacturers in depth—details product specs, capacity, sales, revenue, margins; Top manufactures 2024 sales breakdowns by Product type, by Application, by sales region SWOT analysis, and recent strategic developments.
  • Chapter 13: Supply chain—analyses upstream raw materials and suppliers, manufacturing footprint and technology, cost drivers, plus downstream channels and distributor roles.
  • Chapter 14: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
  • Chapter 15: Actionable conclusions and strategic recommendations.
  • Why This Report:
  • Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
  • Allocate capital strategically to high growth regions (Chapters 7–11) and margin rich segments (Chapter 5).
  • Negotiate from strength with suppliers (Chapter 13) and customers (Chapter 6) using cost and demand intelligence.
  • Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 4 and 12).
  • Secure your supply chain against disruptions through upstream and downstream visibility (Chapters 13 and 14).
  • Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.

FAQ for this report

Who are the main players in the Trans-p-hydroxycinnamicacid Market report?

Ans: The main players in the Trans-p-hydroxycinnamicacid Market are Shanxi Yongjin Group, Blue California, Zaoyang Cixiang Medical Technology, Changzhou Mingsheng Biotechnology, Wuhan Landmark Industrial, Shandong Yangcheng Biotechnology

What are the Application segmentation covered in the Trans-p-hydroxycinnamicacid Market report?

Ans: The Applications covered in the Trans-p-hydroxycinnamicacid Market report are Medical, Agriculture, Cosmetics, Electronics, Others

What are the Type segmentation covered in the Trans-p-hydroxycinnamicacid Market report?

Ans: The Types covered in the Trans-p-hydroxycinnamicacid Market report are Purity≥98%, Purity≥99%, Others

1 Study Coverage
1.1 Introduction to Trans-p-hydroxycinnamicacid: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global Trans-p-hydroxycinnamicacid Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 Purity≥98%
1.2.3 Purity≥99%
1.2.4 Others
1.3 Market Segmentation by Application
1.3.1 Global Trans-p-hydroxycinnamicacid Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Medical
1.3.3 Agriculture
1.3.4 Cosmetics
1.3.5 Electronics
1.3.6 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Trans-p-hydroxycinnamicacid Revenue Estimates and Forecasts 2020-2031
2.2 Global Trans-p-hydroxycinnamicacid Revenue by Region
2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031
2.2.2 Historical and Forecasted Revenue by Region (2020--2031)
2.2.3 Global Revenue Market Share by Region (2020-2031)
2.3 Global Trans-p-hydroxycinnamicacid Sales Estimates and Forecasts 2020-2031
2.4 Global Trans-p-hydroxycinnamicacid Sales by Region
2.4.1 Sales Comparison: 2020 VS 2024 VS 2031
2.4.2 Historical and Forecasted Sales by Region (2020-2031)
2.4.3 Emerging Market Focus: Growth Drivers & Investment Trends
2.4.4 Global Sales Market Share by Region (2020-2031)
3 Global Production Analysis
3.1 Global Trans-p-hydroxycinnamicacid Production Capacity and Utilization Rates (2020–2031)
3.2 Regional Production: Comparative Analysis (2020 VS 2024 VS 2031)
3.3 Regional Production Dynamics
3.3.1 Historic Production by Region (2020-2025)
3.3.2 Forecasted Production by Region (2026-2031)
3.3.3 Production Market Share by Region (2020-2031)
3.3.4 Regulatory and Trade Policy Impact on Production
3.3.5 Production Capacity Enablers and Constraints
3.4 Key Regional Production Hubs
3.4.1 North America
3.4.2 Europe
3.4.3 China
3.4.4 Japan
4 Competition by Manufacturers
4.1 Global Trans-p-hydroxycinnamicacid Sales by Manufacturers
4.1.1 Global Sales Volume by Manufacturers (2020-2025)
4.1.2 Global Top 5 and Top 10 Manufacturers’Market Share by Sales Volume (2024)
4.2 Global Trans-p-hydroxycinnamicacid Manufacturer Revenue Rankings and Tiers
4.2.1 Global Revenue (Value) by Manufacturers (2020-2025)
4.2.2 Global Key Manufacturer Revenue Ranking (2023 vs. 2024)
4.2.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
4.3 Manufacturer Profitability Profiles and Pricing Strategies
4.3.1 Gross Margin by Top Manufacturer (2020 VS 2024)
4.3.2 Manufacturer-Level Price Trends (2020-2025)
4.4 Key Manufacturers Manufacturing Base and Headquarters
4.5 Main Product Type Market Size by Manufacturers
4.5.1 Purity≥98% Market Size by Manufacturers
4.5.2 Purity≥99% Market Size by Manufacturers
4.5.3 Others Market Size by Manufacturers
4.6 Global Trans-p-hydroxycinnamicacid Market Concentration and Dynamics
4.6.1 Global Market Concentration (CR5 and HHI)
4.6.2 Entrant/Exit Impact Analysis
4.6.3 Strategic Moves: M&A, Capacity Expansion, R&D Investment
5 Global Product Segmentation Analysis
5.1 Global Trans-p-hydroxycinnamicacid Sales Performance by Type
5.1.1 Global Historical and Forecasted Sales by Type (2020-2031)
5.1.2 Global Sales Market Share by Type (2020-2031)
5.2 Global Trans-p-hydroxycinnamicacid Revenue Trends by Type
5.2.1 Global Historical and Forecasted Revenue by Type (2020-2031)
5.2.2 Global Revenue Market Share by Type (2020-2031)
5.3 Global Average Selling Price (ASP) Trends by Type (2020-2031)
5.4 Product Technology Differentiation
5.5 Subtype Dynamics: Growth Leaders, Profitability and Risk
5.5.1 High-Growth Niches and Adoption Drivers
5.5.2 Profitability Hotspots and Cost Drivers
5.5.3 Substitution Threats
6 Global Downstream Application Analysis
6.1 Global Trans-p-hydroxycinnamicacid Sales by Application
6.1.1 Global Historical and Forecasted Sales by Application (2020-2031)
6.1.2 Global Sales Market Share by Application (2020-2031)
6.1.3 High-Growth Application Identification
6.1.4 Emerging Application Case Studies
6.2 Global Trans-p-hydroxycinnamicacid Revenue by Application
6.2.1 Global Historical and Forecasted Revenue by Application (2020-2031)
6.2.2 Revenue Market Share by Application (2020-2031)
6.3 Global Pricing Dynamics by Application (2020-2031)
6.4 Downstream Customer Analysis
6.4.1 Top Customers by Region
6.4.2 Top Customers by Application
7 North America
7.1 North America Sales Volume and Revenue (2020-2031)
7.2 North America Key Manufacturers Sales Revenue in 2024
7.3 North America Trans-p-hydroxycinnamicacid Sales and Revenue by Type (2020-2031)
7.4 North America Trans-p-hydroxycinnamicacid Sales and Revenue by Application (2020-2031)
7.5 North America Growth Accelerators and Market Barriers
7.6 North America Trans-p-hydroxycinnamicacid Market Size by Country
7.6.1 North America Revenue by Country
7.6.2 North America Sales Trends by Country
7.6.3 US
7.6.4 Canada
7.6.5 Mexico
8 Europe
8.1 Europe Sales Volume and Revenue (2020-2031)
8.2 Europe Key Manufacturers Sales Revenue in 2024
8.3 Europe Trans-p-hydroxycinnamicacid Sales and Revenue by Type (2020-2031)
8.4 Europe Trans-p-hydroxycinnamicacid Sales and Revenue by Application (2020-2031)
8.5 Europe Growth Accelerators and Market Barriers
8.6 Europe Trans-p-hydroxycinnamicacid Market Size by Country
8.6.1 Europe Revenue by Country
8.6.2 Europe Sales Trends by Country
8.6.3 Germany
8.6.4 France
8.6.5 U.K.
8.6.6 Italy
8.6.7 Russia
9 Asia-Pacific
9.1 Asia-Pacific Sales Volume and Revenue (2020-2031)
9.2 Asia-Pacific Key Manufacturers Sales Revenue in 2024
9.3 Asia-Pacific Trans-p-hydroxycinnamicacid Sales and Revenue by Type (2020-2031)
9.4 Asia-Pacific Trans-p-hydroxycinnamicacid Sales and Revenue by Application (2020-2031)
9.5 Asia-Pacific Trans-p-hydroxycinnamicacid Market Size by Region
9.5.1 Asia-Pacific Revenue by Region
9.5.2 Asia-Pacific Sales Trends by Region
9.6 Asia-Pacific Growth Accelerators and Market Barriers
9.7 Southeast Asia
9.7.1 Southeast Asia Revenue by Country (2020 VS 2024 VS 2031)
9.7.2 Key Country Analysis: Indonesia, Vietnam, Thailand
9.8 China
9.9 Japan
9.10 South Korea
9.11 China Taiwan
9.12 India
10 Central and South America
10.1 Central and South America Sales Volume and Revenue (2020-2031)
10.2 Central and South America Key Manufacturers Sales Revenue in 2024
10.3 Central and South America Trans-p-hydroxycinnamicacid Sales and Revenue by Type (2020-2031)
10.4 Central and South America Trans-p-hydroxycinnamicacid Sales and Revenue by Application (2020-2031)
10.5 Central and South America Investment Opportunities and Key Challenges
10.6 Central and South America Trans-p-hydroxycinnamicacid Market Size by Country
10.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)
10.6.2 Brazil
10.6.3 Argentina
11 Middle East and Africa
11.1 Middle East and Africa Sales Volume and Revenue (2020-2031)
11.2 Middle East and Africa Key Manufacturers Sales Revenue in 2024
11.3 Middle East and Africa Trans-p-hydroxycinnamicacid Sales and Revenue by Type (2020-2031)
11.4 Middle East and Africa Trans-p-hydroxycinnamicacid Sales and Revenue by Application (2020-2031)
11.5 Middle East and Africa Investment Opportunities and Key Challenges
11.6 Middle East and Africa Trans-p-hydroxycinnamicacid Market Size by Country
11.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)
11.6.2 GCC Countries
11.6.3 Turkey
11.6.4 Egypt
11.6.5 South Africa
12 Corporate Profile
12.1 Shanxi Yongjin Group
12.1.1 Shanxi Yongjin Group Corporation Information
12.1.2 Shanxi Yongjin Group Business Overview
12.1.3 Shanxi Yongjin Group Trans-p-hydroxycinnamicacid Product Models, Descriptions and Specifications
12.1.4 Shanxi Yongjin Group Trans-p-hydroxycinnamicacid Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.1.5 Shanxi Yongjin Group Trans-p-hydroxycinnamicacid Sales by Product in 2024
12.1.6 Shanxi Yongjin Group Trans-p-hydroxycinnamicacid Sales by Application in 2024
12.1.7 Shanxi Yongjin Group Trans-p-hydroxycinnamicacid Sales by Geographic Area in 2024
12.1.8 Shanxi Yongjin Group Trans-p-hydroxycinnamicacid SWOT Analysis
12.1.9 Shanxi Yongjin Group Recent Developments
12.2 Blue California
12.2.1 Blue California Corporation Information
12.2.2 Blue California Business Overview
12.2.3 Blue California Trans-p-hydroxycinnamicacid Product Models, Descriptions and Specifications
12.2.4 Blue California Trans-p-hydroxycinnamicacid Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.2.5 Blue California Trans-p-hydroxycinnamicacid Sales by Product in 2024
12.2.6 Blue California Trans-p-hydroxycinnamicacid Sales by Application in 2024
12.2.7 Blue California Trans-p-hydroxycinnamicacid Sales by Geographic Area in 2024
12.2.8 Blue California Trans-p-hydroxycinnamicacid SWOT Analysis
12.2.9 Blue California Recent Developments
12.3 Zaoyang Cixiang Medical Technology
12.3.1 Zaoyang Cixiang Medical Technology Corporation Information
12.3.2 Zaoyang Cixiang Medical Technology Business Overview
12.3.3 Zaoyang Cixiang Medical Technology Trans-p-hydroxycinnamicacid Product Models, Descriptions and Specifications
12.3.4 Zaoyang Cixiang Medical Technology Trans-p-hydroxycinnamicacid Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.3.5 Zaoyang Cixiang Medical Technology Trans-p-hydroxycinnamicacid Sales by Product in 2024
12.3.6 Zaoyang Cixiang Medical Technology Trans-p-hydroxycinnamicacid Sales by Application in 2024
12.3.7 Zaoyang Cixiang Medical Technology Trans-p-hydroxycinnamicacid Sales by Geographic Area in 2024
12.3.8 Zaoyang Cixiang Medical Technology Trans-p-hydroxycinnamicacid SWOT Analysis
12.3.9 Zaoyang Cixiang Medical Technology Recent Developments
12.4 Changzhou Mingsheng Biotechnology
12.4.1 Changzhou Mingsheng Biotechnology Corporation Information
12.4.2 Changzhou Mingsheng Biotechnology Business Overview
12.4.3 Changzhou Mingsheng Biotechnology Trans-p-hydroxycinnamicacid Product Models, Descriptions and Specifications
12.4.4 Changzhou Mingsheng Biotechnology Trans-p-hydroxycinnamicacid Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.4.5 Changzhou Mingsheng Biotechnology Trans-p-hydroxycinnamicacid Sales by Product in 2024
12.4.6 Changzhou Mingsheng Biotechnology Trans-p-hydroxycinnamicacid Sales by Application in 2024
12.4.7 Changzhou Mingsheng Biotechnology Trans-p-hydroxycinnamicacid Sales by Geographic Area in 2024
12.4.8 Changzhou Mingsheng Biotechnology Trans-p-hydroxycinnamicacid SWOT Analysis
12.4.9 Changzhou Mingsheng Biotechnology Recent Developments
12.5 Wuhan Landmark Industrial
12.5.1 Wuhan Landmark Industrial Corporation Information
12.5.2 Wuhan Landmark Industrial Business Overview
12.5.3 Wuhan Landmark Industrial Trans-p-hydroxycinnamicacid Product Models, Descriptions and Specifications
12.5.4 Wuhan Landmark Industrial Trans-p-hydroxycinnamicacid Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.5.5 Wuhan Landmark Industrial Trans-p-hydroxycinnamicacid Sales by Product in 2024
12.5.6 Wuhan Landmark Industrial Trans-p-hydroxycinnamicacid Sales by Application in 2024
12.5.7 Wuhan Landmark Industrial Trans-p-hydroxycinnamicacid Sales by Geographic Area in 2024
12.5.8 Wuhan Landmark Industrial Trans-p-hydroxycinnamicacid SWOT Analysis
12.5.9 Wuhan Landmark Industrial Recent Developments
12.6 Shandong Yangcheng Biotechnology
12.6.1 Shandong Yangcheng Biotechnology Corporation Information
12.6.2 Shandong Yangcheng Biotechnology Business Overview
12.6.3 Shandong Yangcheng Biotechnology Trans-p-hydroxycinnamicacid Product Models, Descriptions and Specifications
12.6.4 Shandong Yangcheng Biotechnology Trans-p-hydroxycinnamicacid Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.6.5 Shandong Yangcheng Biotechnology Recent Developments
13 Value Chain and Supply-Chain Analysis
13.1 Trans-p-hydroxycinnamicacid Industry Chain
13.2 Trans-p-hydroxycinnamicacid Upstream Materials Analysis
13.2.1 Raw Materials
13.2.2 Key Suppliers Market Share & Risk Assessment
13.3 Trans-p-hydroxycinnamicacid Integrated Production Analysis
13.3.1 Manufacturing Footprint Analysis
13.3.2 Production Technology Overview
13.3.3 Regional Cost Drivers
13.4 Trans-p-hydroxycinnamicacid Sales Channels and Distribution Networks
13.4.1 Sales Channels
13.4.2 Distributors
14 Trans-p-hydroxycinnamicacid Market Dynamics
14.1 Industry Trends and Evolution
14.2 Market Growth Drivers and Emerging Opportunities
14.3 Market Challenges, Risks, and Restraints
15 Key Findings in the Global Trans-p-hydroxycinnamicacid Study
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.1.1 Research Programs/Design
16.1.1.2 Market Size Estimation
16.1.1.3 Market Breakdown and Data Triangulation
16.1.2 Data Source
16.1.2.1 Secondary Sources
16.1.2.2 Primary Sources
16.2 Author Details
List of Tables
 Table 1. Global Trans-p-hydroxycinnamicacid Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
 Table 2. Global Trans-p-hydroxycinnamicacid Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
 Table 3. Global Trans-p-hydroxycinnamicacid Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 4. Global Trans-p-hydroxycinnamicacid Revenue by Region (2020-2025) & (US$ Million)
 Table 5. Global Trans-p-hydroxycinnamicacid Revenue by Region (2026-2031) & (US$ Million)
 Table 6. Global Trans-p-hydroxycinnamicacid Sales Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (Tons)
 Table 7. Global Trans-p-hydroxycinnamicacid Sales by Region (2020-2025) & (Tons)
 Table 8. Global Trans-p-hydroxycinnamicacid Sales by Region (2026-2031) & (Tons)
 Table 9. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 10. Global Trans-p-hydroxycinnamicacid Production Growth Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (Tons)
 Table 11. Global Trans-p-hydroxycinnamicacid Production by Region (2020-2025) & (Tons)
 Table 12. Global Trans-p-hydroxycinnamicacid Production by Region (2026-2031) & (Tons)
 Table 13. Global Trans-p-hydroxycinnamicacid Sales by Manufacturers (2020-2025) & (Tons)
 Table 14. Global Trans-p-hydroxycinnamicacid Sales Share by Manufacturers (2020-2025)
 Table 15. Global Trans-p-hydroxycinnamicacid Revenue by Manufacturers (2020-2025) & (US$ Million)
 Table 16. Global Trans-p-hydroxycinnamicacid Revenue Market Share by Manufacturers (2020-2025)
 Table 17. Global Key Manufacturers’Ranking Shift (2023 vs. 2024) (Based on Revenue)
 Table 18. Global Trans-p-hydroxycinnamicacid by Manufacturer Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Trans-p-hydroxycinnamicacid as of 2024)
 Table 19. Global Trans-p-hydroxycinnamicacid Average Gross Margin (%) by Manufacturer (2020 VS 2024)
 Table 20. Global Trans-p-hydroxycinnamicacid Average Selling Price (ASP) by Manufacturers (2020-2025) & (US$/Ton)
 Table 21. Key Manufacturers Trans-p-hydroxycinnamicacid Manufacturing Base and Headquarters
 Table 22. Global Trans-p-hydroxycinnamicacid Market Concentration Ratio (CR5 and HHI)
 Table 23. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
 Table 24. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
 Table 25. Global Trans-p-hydroxycinnamicacid Sales by Type (2020-2025) & (Tons)
 Table 26. Global Trans-p-hydroxycinnamicacid Sales by Type (2026-2031) & (Tons)
 Table 27. Global Trans-p-hydroxycinnamicacid Revenue by Type (2020-2025) & (US$ Million)
 Table 28. Global Trans-p-hydroxycinnamicacid Revenue by Type (2026-2031) & (US$ Million)
 Table 29. Global Trans-p-hydroxycinnamicacid ASP by Type (2020-2031) & (US$/Ton)
 Table 30. Technical Specifications by Key Product Type
 Table 31. Global Trans-p-hydroxycinnamicacid Sales by Application (2020-2025) & (Tons)
 Table 32. Global Trans-p-hydroxycinnamicacid Sales by Application (2026-2031) & (Tons)
 Table 33. Trans-p-hydroxycinnamicacid High-Growth Sectors Demand CAGR (2024-2031)
 Table 34. Global Trans-p-hydroxycinnamicacid Revenue by Application (2020-2025) & (US$ Million)
 Table 35. Global Trans-p-hydroxycinnamicacid Revenue by Application (2026-2031) & (US$ Million)
 Table 36. Global Trans-p-hydroxycinnamicacid ASP by Application (2020-2031) & (US$/Ton)
 Table 37. Top Customers by Region
 Table 38. Top Customers by Application
 Table 39. North America Trans-p-hydroxycinnamicacid Growth Accelerators and Market Barriers
 Table 40. North America Trans-p-hydroxycinnamicacid Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 41. North America Trans-p-hydroxycinnamicacid Sales (Tons) by Country (2020 VS 2024 VS 2031)
 Table 42. Europe Trans-p-hydroxycinnamicacid Growth Accelerators and Market Barriers
 Table 43. Europe Trans-p-hydroxycinnamicacid Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 44. Europe Trans-p-hydroxycinnamicacid Sales (Tons) by Country (2020 VS 2024 VS 2031)
 Table 45. Asia-Pacific Trans-p-hydroxycinnamicacid Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Asia-Pacific Trans-p-hydroxycinnamicacid Sales (Tons) by Country (2020 VS 2024 VS 2031)
 Table 47. Asia-Pacific Trans-p-hydroxycinnamicacid Growth Accelerators and Market Barriers
 Table 48. Southeast Asia Trans-p-hydroxycinnamicacid Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 49. Central and South America Trans-p-hydroxycinnamicacid Investment Opportunities and Key Challenges
 Table 50. Central and South America Trans-p-hydroxycinnamicacid Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 51. Middle East and Africa Trans-p-hydroxycinnamicacid Investment Opportunities and Key Challenges
 Table 52. Middle East and Africa Trans-p-hydroxycinnamicacid Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 53. Shanxi Yongjin Group Corporation Information
 Table 54. Shanxi Yongjin Group Description and Major Businesses
 Table 55. Shanxi Yongjin Group Product Models, Descriptions and Specifications
 Table 56. Shanxi Yongjin Group Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 57. Shanxi Yongjin Group Sales Value Proportion by Product in 2024
 Table 58. Shanxi Yongjin Group Sales Value Proportion by Application in 2024
 Table 59. Shanxi Yongjin Group Sales Value Proportion by Geographic Area in 2024
 Table 60. Shanxi Yongjin Group Trans-p-hydroxycinnamicacid SWOT Analysis
 Table 61. Shanxi Yongjin Group Recent Developments
 Table 62. Blue California Corporation Information
 Table 63. Blue California Description and Major Businesses
 Table 64. Blue California Product Models, Descriptions and Specifications
 Table 65. Blue California Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 66. Blue California Sales Value Proportion by Product in 2024
 Table 67. Blue California Sales Value Proportion by Application in 2024
 Table 68. Blue California Sales Value Proportion by Geographic Area in 2024
 Table 69. Blue California Trans-p-hydroxycinnamicacid SWOT Analysis
 Table 70. Blue California Recent Developments
 Table 71. Zaoyang Cixiang Medical Technology Corporation Information
 Table 72. Zaoyang Cixiang Medical Technology Description and Major Businesses
 Table 73. Zaoyang Cixiang Medical Technology Product Models, Descriptions and Specifications
 Table 74. Zaoyang Cixiang Medical Technology Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 75. Zaoyang Cixiang Medical Technology Sales Value Proportion by Product in 2024
 Table 76. Zaoyang Cixiang Medical Technology Sales Value Proportion by Application in 2024
 Table 77. Zaoyang Cixiang Medical Technology Sales Value Proportion by Geographic Area in 2024
 Table 78. Zaoyang Cixiang Medical Technology Trans-p-hydroxycinnamicacid SWOT Analysis
 Table 79. Zaoyang Cixiang Medical Technology Recent Developments
 Table 80. Changzhou Mingsheng Biotechnology Corporation Information
 Table 81. Changzhou Mingsheng Biotechnology Description and Major Businesses
 Table 82. Changzhou Mingsheng Biotechnology Product Models, Descriptions and Specifications
 Table 83. Changzhou Mingsheng Biotechnology Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 84. Changzhou Mingsheng Biotechnology Sales Value Proportion by Product in 2024
 Table 85. Changzhou Mingsheng Biotechnology Sales Value Proportion by Application in 2024
 Table 86. Changzhou Mingsheng Biotechnology Sales Value Proportion by Geographic Area in 2024
 Table 87. Changzhou Mingsheng Biotechnology Trans-p-hydroxycinnamicacid SWOT Analysis
 Table 88. Changzhou Mingsheng Biotechnology Recent Developments
 Table 89. Wuhan Landmark Industrial Corporation Information
 Table 90. Wuhan Landmark Industrial Description and Major Businesses
 Table 91. Wuhan Landmark Industrial Product Models, Descriptions and Specifications
 Table 92. Wuhan Landmark Industrial Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 93. Wuhan Landmark Industrial Sales Value Proportion by Product in 2024
 Table 94. Wuhan Landmark Industrial Sales Value Proportion by Application in 2024
 Table 95. Wuhan Landmark Industrial Sales Value Proportion by Geographic Area in 2024
 Table 96. Wuhan Landmark Industrial Trans-p-hydroxycinnamicacid SWOT Analysis
 Table 97. Wuhan Landmark Industrial Recent Developments
 Table 98. Shandong Yangcheng Biotechnology Corporation Information
 Table 99. Shandong Yangcheng Biotechnology Description and Major Businesses
 Table 100. Shandong Yangcheng Biotechnology Product Models, Descriptions and Specifications
 Table 101. Shandong Yangcheng Biotechnology Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 102. Shandong Yangcheng Biotechnology Recent Developments
 Table 103. Key Raw Materials Distribution
 Table 104. Raw Materials Key Suppliers
 Table 105. Critical Raw Material Supplier Concentration (2024) & Risk Index
 Table 106. Milestones in Production Technology Evolution
 Table 107. Distributors List
 Table 108. Market Trends and Market Evolution
 Table 109. Market Drivers and Opportunities
 Table 110. Market Challenges, Risks, and Restraints
 Table 111. Research Programs/Design for This Report
 Table 112. Key Data Information from Secondary Sources
 Table 113. Key Data Information from Primary Sources


List of Figures
 Figure 1. Trans-p-hydroxycinnamicacid Product Picture
 Figure 2. Global Trans-p-hydroxycinnamicacid Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
 Figure 3. Purity≥98% Product Picture
 Figure 4. Purity≥99% Product Picture
 Figure 5. Others Product Picture
 Figure 6. Global Trans-p-hydroxycinnamicacid Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
 Figure 7. Medical
 Figure 8. Agriculture
 Figure 9. Cosmetics
 Figure 10. Electronics
 Figure 11. Others
 Figure 12. Trans-p-hydroxycinnamicacid Report Years Considered
 Figure 13. Global Trans-p-hydroxycinnamicacid Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 14. Global Trans-p-hydroxycinnamicacid Revenue (2020-2031) & (US$ Million)
 Figure 15. Global Trans-p-hydroxycinnamicacid Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Figure 16. Global Trans-p-hydroxycinnamicacid Revenue Market Share by Region (2020-2031)
 Figure 17. Global Trans-p-hydroxycinnamicacid Sales (2020-2031) & (Tons)
 Figure 18. Global Trans-p-hydroxycinnamicacid Sales (CAGR) by Region (2020-2031) (Tons)
 Figure 19. Global Trans-p-hydroxycinnamicacid Sales Market Share by Region (2020-2031)
 Figure 20. Global Trans-p-hydroxycinnamicacid Capacity, Production and Utilization (2020-2031) & (Tons)
 Figure 21. Global Trans-p-hydroxycinnamicacid Production Trend by Region (2020-2031) (Tons)
 Figure 22. Global Trans-p-hydroxycinnamicacid Production Market Share by Region (2020-2031)
 Figure 23. Production Capacity Enablers & Constraints
 Figure 24. Trans-p-hydroxycinnamicacid Production Growth Rate in North America (2020-2031) & (Tons)
 Figure 25. Trans-p-hydroxycinnamicacid Production Growth Rate in Europe (2020-2031) & (Tons)
 Figure 26. Trans-p-hydroxycinnamicacid Production Growth Rate in China (2020-2031) & (Tons)
 Figure 27. Trans-p-hydroxycinnamicacid Production Growth Rate in Japan (2020-2031) & (Tons)
 Figure 28. Top 5 and Top 10 Manufacturers Trans-p-hydroxycinnamicacid Sales Volume Market Share in 2024
 Figure 29. Global Trans-p-hydroxycinnamicacid Revenue Market Share Ranking (2024)
 Figure 30. Tier Distribution by Revenue Contribution (2020 VS 2024)
 Figure 31. Purity≥98% Revenue Market Share by Manufacturer in 2024
 Figure 32. Purity≥99% Revenue Market Share by Manufacturer in 2024
 Figure 33. Others Revenue Market Share by Manufacturer in 2024
 Figure 34. Type Eight Revenue Market Share by Manufacturer in 2024
 Figure 35. Type Nine Revenue Market Share by Manufacturer in 2024
 Figure 36. Global Trans-p-hydroxycinnamicacid Sales Market Share by Type (2020-2031)
 Figure 37. Global Trans-p-hydroxycinnamicacid Revenue Market Share by Type (2020-2031)
 Figure 38. Global Trans-p-hydroxycinnamicacid Sales Market Share by Application (2020-2031)
 Figure 39. Global Trans-p-hydroxycinnamicacid Revenue Market Share by Application (2020-2031)
 Figure 40. North America Trans-p-hydroxycinnamicacid Sales YoY (2020-2031) & (Tons)
 Figure 41. North America Trans-p-hydroxycinnamicacid Revenue YoY (2020-2031) & (US$ Million)
 Figure 42. North America Top 5 Manufacturers Trans-p-hydroxycinnamicacid Sales Revenue (US$ Million) in 2024
 Figure 43. North America Trans-p-hydroxycinnamicacid Sales Volume (Tons) by Type (2020- 2031)
 Figure 44. North America Trans-p-hydroxycinnamicacid Sales Revenue (US$ Million) by Type (2020 - 2031)
 Figure 45. North America Trans-p-hydroxycinnamicacid Sales Volume (Tons) by Application (2020-2031)
 Figure 46. North America Trans-p-hydroxycinnamicacid Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 47. US Trans-p-hydroxycinnamicacid Revenue (2020-2031) & (US$ Million)
 Figure 48. Canada Trans-p-hydroxycinnamicacid Revenue (2020-2031) & (US$ Million)
 Figure 49. Mexico Trans-p-hydroxycinnamicacid Revenue (2020-2031) & (US$ Million)
 Figure 50. Europe Trans-p-hydroxycinnamicacid Sales YoY (2020-2031) & (Tons)
 Figure 51. Europe Trans-p-hydroxycinnamicacid Revenue YoY (2020-2031) & (US$ Million)
 Figure 52. Europe Top 5 Manufacturers Trans-p-hydroxycinnamicacid Sales Revenue (US$ Million) in 2024
 Figure 53. Europe Trans-p-hydroxycinnamicacid Sales Volume (Tons) by Type (2020-2031)
 Figure 54. Europe Trans-p-hydroxycinnamicacid Sales Revenue (US$ Million) by Type (2020-2031)
 Figure 55. Europe Trans-p-hydroxycinnamicacid Sales Volume (Tons) by Application (2020-2031)
 Figure 56. Europe Trans-p-hydroxycinnamicacid Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 57. Germany Trans-p-hydroxycinnamicacid Revenue (2020-2031) & (US$ Million)
 Figure 58. France Trans-p-hydroxycinnamicacid Revenue (2020-2031) & (US$ Million)
 Figure 59. U.K. Trans-p-hydroxycinnamicacid Revenue (2020-2031) & (US$ Million)
 Figure 60. Italy Trans-p-hydroxycinnamicacid Revenue (2020-2031) & (US$ Million)
 Figure 61. Russia Trans-p-hydroxycinnamicacid Revenue (2020-2031) & (US$ Million)
 Figure 62. Asia-Pacific Trans-p-hydroxycinnamicacid Sales YoY (2020-2031) & (Tons)
 Figure 63. Asia-Pacific Trans-p-hydroxycinnamicacid Revenue YoY (2020-2031) & (US$ Million)
 Figure 64. Asia-Pacific Top 8 Manufacturers Trans-p-hydroxycinnamicacid Sales Revenue (US$ Million) in 2024
 Figure 65. Asia-Pacific Trans-p-hydroxycinnamicacid Sales Volume (Tons) by Type (2020- 2031)
 Figure 66. Asia-Pacific Trans-p-hydroxycinnamicacid Sales Revenue (US$ Million) by Type (2020- 2031)
 Figure 67. Asia-Pacific Trans-p-hydroxycinnamicacid Sales Volume (Tons) by Application (2020-2031)
 Figure 68. Asia-Pacific Trans-p-hydroxycinnamicacid Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 69. Indonesia Trans-p-hydroxycinnamicacid Revenue (2020-2031) & (US$ Million)
 Figure 70. Japan Trans-p-hydroxycinnamicacid Revenue (2020-2031) & (US$ Million)
 Figure 71. South Korea Trans-p-hydroxycinnamicacid Revenue (2020-2031) & (US$ Million)
 Figure 72. China Taiwan Trans-p-hydroxycinnamicacid Revenue (2020-2031) & (US$ Million)
 Figure 73. India Trans-p-hydroxycinnamicacid Revenue (2020-2031) & (US$ Million)
 Figure 74. Central and South America Trans-p-hydroxycinnamicacid Sales YoY (2020-2031) & (Tons)
 Figure 75. Central and South America Trans-p-hydroxycinnamicacid Revenue YoY (2020-2031) & (US$ Million)
 Figure 76. Central and South America Top 5 Manufacturers Trans-p-hydroxycinnamicacid Sales Revenue (US$ Million) in 2024
 Figure 77. Central and South America Trans-p-hydroxycinnamicacid Sales Volume (Tons) by Type (2021-2031)
 Figure 78. Central and South America Trans-p-hydroxycinnamicacid Sales Revenue (US$ Million) by Type (2020-2031)
 Figure 79. Central and South America Trans-p-hydroxycinnamicacid Sales Volume (Tons) by Application (2020-2031)
 Figure 80. Central and South America Trans-p-hydroxycinnamicacid Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 81. Brazil Trans-p-hydroxycinnamicacid Revenue (2020-2025) & (US$ Million)
 Figure 82. Argentina Trans-p-hydroxycinnamicacid Revenue (2020-2025) & (US$ Million)
 Figure 83. Middle East, and Africa Trans-p-hydroxycinnamicacid Sales YoY (2020-2031) & (Tons)
 Figure 84. Middle East and Africa Trans-p-hydroxycinnamicacid Revenue YoY (2020-2031) & (US$ Million)
 Figure 85. Middle East and Africa Top 5 Manufacturers Trans-p-hydroxycinnamicacid Sales Revenue (US$ Million) in 2024
 Figure 86. Middle East and Africa Trans-p-hydroxycinnamicacid Sales Volume (Tons) by Type (2021-2031)
 Figure 87. South America Trans-p-hydroxycinnamicacid Sales Revenue (US$ Million) by Type (2020-2031)
 Figure 88. Middle East and Africa Trans-p-hydroxycinnamicacid Sales Volume (Tons) by Application (2020-2031)
 Figure 89. Middle East and Africa Trans-p-hydroxycinnamicacid Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 90. GCC Countries Trans-p-hydroxycinnamicacid Revenue (2020-2025) & (US$ Million)
 Figure 91. Turkey Trans-p-hydroxycinnamicacid Revenue (2020-2025) & (US$ Million)
 Figure 92. Egypt Trans-p-hydroxycinnamicacid Revenue (2020-2025) & (US$ Million)
 Figure 93. South Africa Trans-p-hydroxycinnamicacid Revenue (2020-2025) & (US$ Million)
 Figure 94. Trans-p-hydroxycinnamicacid Industry Chain Mapping
 Figure 95. Regional Trans-p-hydroxycinnamicacid Manufacturing Base Distribution (%)
 Figure 96. Trans-p-hydroxycinnamicacid Production Process
 Figure 97. Regional Trans-p-hydroxycinnamicacid Production Cost Structure
 Figure 98. Channels of Distribution (Direct Vs Distribution)
 Figure 99. Bottom-up and Top-down Approaches for This Report
 Figure 100. Data Triangulation
 Figure 101. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$4900

This license allows only one user to access the PDF.
Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Strategic Venue Partners

SIMILAR REPORTS

RELATED REPORTS

Global Hafnium Tetrachloride Precursor Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-16Z20178
Wed Dec 03 00:00:00 UTC 2025

Add to Cart

Global Homogeneous Membrane Market Outlook, In‑Depth Analysis & Forecast to 2031

120 Pages
Type: Report
Code: QYRE-Auto-26W16266
Fri Nov 14 00:00:00 UTC 2025

Add to Cart

Global Homogeneous Ion Exchange Membrane Market Outlook, In‑Depth Analysis & Forecast to 2031

120 Pages
Type: Report
Code: QYRE-Auto-3A16695
Fri Nov 14 00:00:00 UTC 2025

Add to Cart

Global Trans-4-Coumaric Acid Market Outlook, In‑Depth Analysis & Forecast to 2031

120 Pages
Type: Report
Code: QYRE-Auto-36B16674
Fri Nov 14 00:00:00 UTC 2025

Add to Cart